Publication | Closed Access

Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models

Hematological MalignancySynergistic EffectAnti-myeloma ActivityMedicineMalignant Blood DisorderVivo Xenograft ModelsImmunologyMyelopoiesisPharmacotherapyPharmacologyTumor MicroenvironmentTumor BiologyMyeloid Neoplasia